Drugs Channel
Topics & Medications
Related Channels

Bortezomib Manufacturer

Available by prescription only, bortezomib (Velcade®) is used in the treatment of multiple myeloma (a type of cancer of the bone marrow) and mantle cell lymphoma (a type of cancer of the white blood cells). It is approved for use in adults only, and is given as an injection by your healthcare provider.
Millennium Pharmaceuticals, Inc., is the manufacturer of bortezomib. Only the brand-name product is available at this time, as patents currently prevent any company from making generic versions of the drug. However, after the first patent expires in May 2017, companies may be able to make generic versions of bortezomib.
Bortezomib is available in one strength: Bortezomib 3.5 mg in a 10-mL vial. Your particular dosage and duration of treatment will depend on the condition being treated, your height and weight, and various other factors.
(For more details, click Generic Velcade. This resource explains who manufactures bortezomib, covers generic availability, and describes the difference between a generic name and a generic version of the medication.)
The Zen of Cancer Caregiving - Recharge Your Batteries!
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.